Home > News Shots > India

By Vinershea | Aug 14, 2020 11:27 AM

As countries are focussed on developing a vaccine for the deadly COVID-19, Hyderabad-based Bharat Biotech is also in the line in developing the vaccine candidate in collaboration with the Indian Council of Medical Research (ICMR) and the National Institute of Virology (NIV). 

bharat biotech ICMR Covaxin safe so far says sources

As per preliminary results of the Phase 1 clinical trials, the COVID-19 vaccine developed by Bharat Biotech and the ICMR - Covaxin is safe. 

"The vaccine is safe. We have not observed any adverse events in any of the volunteers at our site," said Savita Verma, the principal investigator who is leading the trial at PGI, Rohtak, told Economic Times.

Further in its report, ET stated that investigators are collecting blood samples to test the immunogenicity of the vaccine. They also expect to complete the Phase 1 trials by the end of August.

"We are in the process of giving a second dose to the healthy volunteers and so far, we have not seen anything unusual event in patients. It is safe," Sanjay Rai, the principal investigator at All India Institute of Medical Sciences, Delhi also told the publication.

Currently, there are 375 volunteers at 12 sites across India, who have enrolled for the clinical trial. However, two doses are being administered to each individual, ET further reported. 

As the pandemic has created a race to develop a vaccine for the novel coronavirus, media reports also suggest that if the process continued smoothly, the vaccine would be available in the first half of 2021.

Other than Bharat Biotech, Zydus Cadila is the other Indian company that has begun human clinical trials of its vaccine candidate. "There is a tremendous pressure on us to develop the vaccine. But for us, safety and quality are paramount. We don't want to kill more people with the wrong vaccine," Krishna Ella, Chairman of Bharat Biotech International, as per Business Standard.

அரசியல், விளையாட்டு, நாட்டுநடப்பு, குற்ற சம்பவங்கள், வர்த்தகம், தொழில்நுட்பம், சினிமா, வாழ்க்கை முறை என பலதரப்பட்ட சுவாரஸ்யமான செய்திகளை தமிழில் படிக்க இங்கு கிளிக் செய்யவும்      



This page contains news relating to various facts and events. The views are generally about current affiars and general topics in diversified areas such as political, international, national, and regional issues, sports, health, travel, lifestyle, technology and business. People having similar interets on the above topics will find this page useful. Bharat biotech ICMR Covaxin safe so far says sources | India News.